New data shows Alzheimer’s drug can slow cognitive decline
(NEW YORK) -- Promising data shows that an Alzheimer's drug can slow cognitive decline.In a phase III clinical trial, with results published Tuesday in The New England Journal of Medicine, the drug, Lecanemab -- developed by Eisai and Biogen Inc. -- slowed the rate... Read More.